Skip to main content

Published locations for Recurrent or metastatic NSCLC: Tiragolumab plus atezolizumab combo shows promise

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Recurrent or metastatic NSCLC: Tiragolumab plus atezolizumab combo shows promise

User login

  • Reset your password
  • /content/recurrent-or-metastatic-nsclc-tiragolumab-plus-atezolizumab-combo-shows-promise
  • /hematology-oncology/article/255645/lung-cancer/recurrent-or-metastatic-nsclc-tiragolumab-plus